COVID - 19 Vaccination Update - Day 510 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 09 JUN 2022 8:12PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 194.74 Crore (1,94,74,38,014) today. More than 13 lakh (13,28,975) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10407503
	2^nd Dose	10046375
	Precaution Dose	5363723
FLWs	1^st Dose	18420270
	2^nd Dose	17594354
	Precaution Dose	9093730
Age Group 12-14 years	1^st Dose	34902823
	2^nd Dose	18832608
Age Group 15-18 years	1^st Dose	59766291
	2^nd Dose	46709312
Age Group 18-44 years	1^st Dose	557493551
	2^nd Dose	493566786
	Precaution Dose	1335417
Age Group 45-59 years	1^st Dose	203308318
	2^nd Dose	191629451
	Precaution Dose	1707915
Over 60 years	1^st Dose	127137724
	2^nd Dose	119568401
	Precaution Dose	20553462
Cumulative 1^st dose administered		1011436480
Cumulative 2^nd dose administered		897947287
Precaution Dose		38054247
Total		1947438014

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 9^th June, 2022 (510^th Day)
HCWs	1^st Dose	38
	2^nd Dose	550
	Precaution Dose	13877
FLWs	1^st Dose	79
	2^nd Dose	1004
	Precaution Dose	38456
Age Group 12-14 years	1^st Dose	95567
	2^nd Dose	219131
Age Group 15-18 years	1^st Dose	38067
	2^nd Dose	104993
Age Group 18-44 years	1^st Dose	34303
	2^nd Dose	378723
	Precaution Dose	54583
Age Group 45-59 years	1^st Dose	5199
	2^nd Dose	81774
	Precaution Dose	37503
Over 60 years	1^st Dose	4801
	2^nd Dose	57277
	Precaution Dose	163050
Cumulative 1^st dose administered		178054
Cumulative 2^nd dose administered		843452
Precaution Dose		307469
Total		1328975

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.